B
Barbara Fisher
Researcher at University of Western Ontario
Publications - 119
Citations - 30412
Barbara Fisher is an academic researcher from University of Western Ontario. The author has contributed to research in topics: Radiation therapy & Temozolomide. The author has an hindex of 40, co-authored 116 publications receiving 26509 citations. Previous affiliations of Barbara Fisher include London Health Sciences Centre & Mayo Clinic.
Papers
More filters
Journal ArticleDOI
Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424.
Barbara Fisher,Stephanie L. Pugh,David R. Macdonald,Arnab Chakravatri,Glenn J. Lesser,Sherry Fox,C. Leland Rogers,Maria Werner-Wasik,Thomas J. Doyle,Jean Paul Bahary,John B. Fiveash,Joseph Bovi,Steven P. Howard,Hsiang Hsuan Michael Yu,David D'Souza,Nadia N. Laack,Igor J. Barani,Young Kwok,Daniel R. Wahl,Jon Strasser,Minhee Won,Minesh P. Mehta +21 more
TL;DR: The long-term results confirmed the findings from the initial report for efficacy suggesting OS and PFS outcomes with the RT-TMZ regimen exceeding historical control control groups treated with radiation alone.
Journal ArticleDOI
Pituitary adenoma in adolescents: a biologically more aggressive disease?
TL;DR: Adolescents with pituitary adenoma who do not receive postoperative radiation should be followed up closely and undergo imaging at more frequent intervals than do adult patients.
Journal ArticleDOI
Effects of Radiation on a Model of Malignant Glioma Invasion
Glenn Bauman,Warren MacDonald,Emi Moore,David A. Ramsey,Barbara Fisher,Verena R. Amberger,Rolando M. Del Maestro,Rolando M. Del Maestro +7 more
TL;DR: Responses to radiation treatment for four malignant glioma cell lines and nine primary human glioblastoma explants were characterized and addition of BCNU and dexamethasone to radiation produced additional inhibition of invasion among the cell Lines and explants but could not suppress invasion entirely.
Journal ArticleDOI
Strong correlation between imaging response and survival among patients with primary central nervous system lymphoma: a secondary analysis of RTOG studies 83-15 and 88-06
Benjamin W. Corn,Carol A. Dolinskas,Charles Scott,Bernadine Donahue,Christopher J. Schultz,Diana F. Nelson,Barbara Fisher +6 more
TL;DR: There is no rationale for radiation dose escalation as a therapeutic strategy to combat PCNSL and the radiotherapy component of the current RTOG Phase II trial now includes relatively low total doses of hyperfractionated irradiation for patients without residual disease as well as a more aggressive chemotherapy regimen.
Journal ArticleDOI
Alterations in Hormone Levels After Adjuvant Chemoradiation in Male Rectal Cancer Patients
TL;DR: Chemoradiation in men with rectal cancer causes persistent increases in FSH and LH levels and decreases in testosterone levels, suggesting a continued decrease in Leydig cell function with time.